Related Experiment Video
Updated: Aug 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Considerations for treating dyslipidemia in special diabetic populations
1USC Keck School of Medicine, Los Angeles, CA, USA.
Abstract:
This is a review of the problem of dyslipidemia and cardiovascular disease (CVD) in special diabetic populations. Clearly all patients with diabetes are at increased risk for CVD compared to non-diabetic populations. But within the subset that is patients with diabetes there are individuals who are particularly vulnerable. These groups include women, who are often overlooked and undertreated for their cardiovascular risk. Additionally, it includes those with fewer resources, many from minority populations, who are at very high risk for poor preventive care and serious cardiovascular morbidity. This review details the risk for CVD in a variety of different diabetic high-risk groups. It then discusses treatment options and approaches that should be employed in these populations.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Angina IV: Management
Atherosclerosis III: Management
